Drug name - Androgel

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8466137 ABBVIE Testosterone gel and method of use Oct, 2026

(4 years from now)

US8466138 ABBVIE Testosterone gel and method of use Oct, 2026

(4 years from now)

US8741881 ABBVIE Testosterone gel and method of use Oct, 2026

(4 years from now)

US8729057 ABBVIE Testosterone gel and method of use Oct, 2026

(4 years from now)

US8754070 ABBVIE Testosterone gel and method of use Oct, 2026

(4 years from now)

US8466136 ABBVIE Testosterone gel and method of use Oct, 2026

(4 years from now)

US8759329 ABBVIE Testosterone gel and method of use Oct, 2026

(4 years from now)

US8486925 ABBVIE Testosterone gel and method of use Oct, 2026

(4 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Treatment: Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone

Dosage: GEL, METERED;TRANSDERMAL; GEL;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
1.62% (20.25MG/1.25GM ACTUATION) GEL, METERED;TRANSDERMAL Prescription
1.62% (20.25MG/1.25GM PACKET) GEL;TRANSDERMAL Discontinued
1.62% (40.5MG/2.5GM PACKET) GEL;TRANSDERMAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.